REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH)
CUSIP: 76152G100
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 12,863,707
- Total 13F shares
- 7,316,794
- Share change
- -415,515
- Total reported value
- $6,939,218
- Put/Call ratio
- 6.6%
- Price per share
- $0.95
- Number of holders
- 47
- Value change
- -$2,147,972
- Number of buys
- 28
- Number of sells
- 20
Quarterly Holders Quick Answers
What is CUSIP 76152G100?
CUSIP 76152G100 identifies RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 76152G100:
Top shareholders of RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
14%
|
1,804,488
|
$3,266,123 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
11%
|
1,384,592
|
$2,506,111 | — | 31 Dec 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
11%
|
1,364,000
|
$2,468,840 | — | 31 Dec 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
13D/G
|
Company |
2.8%
from 13D/G
|
1,058,100
|
$1,915,161 | — | 31 Dec 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
4%
|
514,273
|
$930,834 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.4%
|
311,701
|
$564,283 | — | 31 Dec 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.6%
|
202,012
|
$365,642 | — | 31 Dec 2024 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.3%
|
170,000
|
$307,700 | — | 31 Dec 2024 | |
| Persistent Asset Partners Ltd |
13F
|
Company |
1.3%
|
161,170
|
$304,611 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.89%
|
115,099
|
$208,329 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.77%
|
99,400
|
$179,914 | — | 31 Dec 2024 | |
| AVANTAX ADVISORY SERVICES, INC. |
13F
|
Company |
0.47%
|
60,000
|
$108,600 | — | 31 Dec 2024 | |
| Focus Partners Wealth |
13F
|
Company |
0.47%
|
60,000
|
$108,600 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.44%
|
56,636
|
$102,511 | — | 31 Dec 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.36%
|
46,467
|
$84,105 | — | 31 Dec 2024 | |
| EMC Capital Management |
13F
|
Company |
0.35%
|
44,535
|
$81,000 | — | 31 Dec 2024 | |
| Engineers Gate Manager LP |
13F
|
Company |
0.27%
|
34,581
|
$62,592 | — | 31 Dec 2024 | |
| Sound Income Strategies, LLC |
13F
|
Company |
0.23%
|
30,000
|
$54,300 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.21%
|
26,775
|
$48,463 | — | 31 Dec 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.19%
|
25,020
|
$45,286 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.16%
|
21,159
|
$38,298 | — | 31 Dec 2024 | |
| DRIVE WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
20,000
|
$36,200 | — | 31 Dec 2024 | |
| Cornerstone Select Advisors, LLC |
13F
|
Company |
0.14%
|
17,500
|
$31,675 | — | 31 Dec 2024 | |
| WOLVERINE TRADING, LLC |
13F
|
Company |
0.11%
|
14,260
|
$25,811 | — | 31 Dec 2024 | |
| RAYMOND JAMES FINANCIAL INC |
13F
|
Company |
0.11%
|
14,000
|
$25,340 | — | 31 Dec 2024 | |
| Vanguard Personalized Indexing Management, LLC |
13F
|
Company |
0.11%
|
13,974
|
$25,293 | — | 31 Dec 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.1%
|
12,892
|
$23,000 | — | 31 Dec 2024 | |
| NRI Wealth Management LC |
13F
|
Company |
0.1%
|
12,380
|
$22,408 | — | 31 Dec 2024 | |
| BluePointe Capital Management, LLC |
13F
|
Company |
0.08%
|
10,378
|
$18,784 | — | 31 Dec 2024 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.07%
|
9,299
|
$16,831 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
6,120
|
$11,077 | — | 31 Dec 2024 | |
| IFP Advisors, Inc |
13F
|
Company |
0.04%
|
4,900
|
$8,869 | — | 31 Dec 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
1,500
|
$3,000 | — | 31 Dec 2024 | |
| Spire Wealth Management |
13F
|
Company |
0.01%
|
1,200
|
$2,172 | — | 31 Dec 2024 | |
| GODSEY & GIBB, INC |
13F
|
Company |
0.01%
|
1,100
|
$1,991 | — | 31 Dec 2024 | |
| Activest Wealth Management |
13F
|
Company |
0.01%
|
1,000
|
$1,810 | — | 31 Dec 2024 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0.01%
|
840
|
$1,520 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
321
|
$581 | — | 31 Dec 2024 | |
| Tradewinds Capital Management, LLC |
13F
|
Company |
0%
|
250
|
$453 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
235
|
$425 | — | 31 Dec 2024 | |
| WOLVERINE ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
122
|
$220 | — | 31 Dec 2024 | |
| R Squared Ltd |
13F
|
Company |
0%
|
30
|
$54 | — | 31 Dec 2024 | |
| VEDANTA PARTNERS, LLC |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
1,127,207
mixed-class rows
|
— | — | 08 Sep 2022 |
Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) as of Q1 2025
As of 31 Mar 2025,
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,316,794 shares.
The largest 10 holders included
VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, DIADEMA PARTNERS LP, TANG CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Schonfeld Strategic Advisors LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, MARSHALL WACE, LLP, and Private Advisor Group, LLC.
This page lists
49
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
42
Q1 2025 holders
47
Holder diff
5
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.